+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aciclovir"

Herpes Zoster Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Herpes Zoster Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Herpes Labialis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Herpes Labialis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Herpes Simplex Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Herpes Simplex Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Epstein Barr Virus Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Epstein Barr Virus Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
From
From
HSV-1 Keratitis - Competitive landscape, 2024 - Product Thumbnail Image

HSV-1 Keratitis - Competitive landscape, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

Aciclovir is an antiviral drug used to treat infections caused by certain types of viruses. It is primarily used to treat herpes simplex virus (HSV) infections, including genital herpes, cold sores, and shingles. It is also used to treat varicella zoster virus (VZV) infections, including chickenpox and shingles. Aciclovir is available in both oral and topical forms, and is often used in combination with other antiviral drugs. Aciclovir is a widely used drug in the treatment of infectious diseases. It is effective against a wide range of viruses, including HSV, VZV, and human cytomegalovirus (HCMV). It is also used to treat other viral infections, such as Epstein-Barr virus (EBV) and human immunodeficiency virus (HIV). Aciclovir is generally well tolerated and has few side effects. Aciclovir is available in many countries, and is marketed by a number of pharmaceutical companies. Some of the companies in the market include GlaxoSmithKline, Novartis, Merck, Pfizer, and Sanofi. Show Less Read more